Differential depth of treatment response required for optimal outcome in patients with blast phase versus chronic phase of chronic myeloid leukemia

Схожие документы

• Homoharringtonine with Imatinib in Chronic, Accelerated, and Blast Phase Chronic Myeloid Leukemia
  по: Maiti, Abhishek, et al.
  Опубликовано: (2017)
• Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia
  по: Kinstrie, Ross, et al.
  Опубликовано: (2016)
• Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy
  по: Chen, Z, et al.
  Опубликовано: (2016)
• Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy
  по: Chen, Z, et al.
  Опубликовано: (2016)
• Extramedullary sudden blast crisis in chronic-phase chronic myeloid leukemia during first-line treatment with nilotinib
  по: Angelopoulou, M K, et al.
  Опубликовано: (2016)